Warner Chilcott Reports Operating Results for the Quarter Ended Septembe... (33.1 19.7 97.3 37.7...)

HOME >> MEDICINE >> NEWS

Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007

Date:11/9/2007

33.1 19.7 97.3 37.7

DORYX 29.2 24.6 84.2 75.3

Total Dermatology 94.3 80.2 288.9 222.6

PMDD

SARAFEM 10.2 8.4 28.5 28.3

Other product sales

Other 0.8 2.8 2.8 7.2

Contract manufacturing 5.9 5.3 21.4 14.7

Total product net sales 223.8 194.7 663.6 548.1

Other revenue

Other non-product revenue 2.7 - 8.3 -

Total revenue $226.5 $194.7 $671.9 $548.1

WARNER CHILCOTT LIMITED

SUMMARY OF SG&A EXPENSES

(In millions of U.S. dollars)

(Unaudited)

Quarter Ended

Sept-30-07 Sept-30-06

Advertising & promotion $11.8 $17.4

Selling & distribution 22.7 20.5

General, administrative & other 26.3 61.8

Total SG&A $60.8 $99.7

Nine Months Ended

Sept-30-07 Sept-30-06

Advertising & promotion $65.5 $55.0

Selling & distribution 66.7 55.7

General, administrative & other 76.6 88.3

Total SG&A $208.8 $199.0

Warner Chilcott Limited

'/>"/>

SOURCE Warner Chilcott Limited
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Related medicine news :

1. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
2. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
3. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
4. Haemacure Reports Third Quarter 2007 Results
5. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
6. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
7. MDS Reports Third Quarter 2007 Results
8. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
9. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
10. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
11. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance

Post Your Comments:

(Date:12/5/2009)NEW ORLEANS, Dec. 5 Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Research presented today at the 51st Annual Meeting of the American Society of Hematology int

(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for

(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W

(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s

(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i

[0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification [0] Distributor Announces New Applications for Wind Turbines [0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children [0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment

...he misuse of ambulances of government hospitals by...g that their services be availed of only by patie...r and Justice S.N. Agrawal said: "No ambulance of ...on a petition, the bench said all vehicles fitted ...

...rnor, James E. McGreevy appears to be knocking on ...n the news for the right reasons. He has been wel...lian. Former Gov. James E. McGreevy, who wa...ly undergoing the church's "discernment" phase, wh...

... when her pictures appeared in magazine articles a... all that blew up, I felt terrible. It appeared th... not. I am thin because that's what I am, and I wa...nightley had just finished filming "Pirates of the...

...tes (UAE) said the government is working to draft ...he country's prevention programme of genetic diso...on the mother or child's health. But the choice to...e ministry of health was quoted as saying in Gulf ...

...onfirmed that the malfunction of a gene causes sch...ublished Thursday's issue of the journal Neuron. ...offer a possible animal model for developing treat...e researchers sought to explore the consequences o...

...aine headaches are more than twice as likely to al...ion or anxiety than soldiers who do not have migr...olved 3,621 United States Army soldiers who were g...cent, completed the questionnaire. Of those, 19 pe...

Other Medicine News:Health News:Malfunction of Gene Causes Schizophrenia, Depression 2 Health News:Migraines may Be a Symptom of Other Problems for Iraq Soldiers 2

High Court Warns Medical Staff Against Misuse of Ambulance Maverick Gay Ex-governor Turns a New Leaf - Accepted at the Episcopalian Seminary 'Skinny' Debate Upsets Actress Knightley Legalization of Therapeutic Abortion in UAE on the Cards Malfunction of Gene Causes Schizophrenia, Depression Migraines may Be a Symptom of Other Problems for Iraq Soldiers

(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab

(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre

(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,

Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8 US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9 Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2 Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2 Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3 Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 1 Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 2 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 1 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 2 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 3 34 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 4 Michael E DeBakey Journalism Award Recipients Announced 49243 1

[0] US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder [0] Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker [0] Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects

..., March 10 BioSpecifics Technologies Corp. (Nasda...g first in class collagenase-based products, today...n, will present a corporate overview at the upcomi...rence on Tuesday, March 17, 2009, at 9:30am ET at ...live webcast of the presentation can be accessed a...

...raClip(R) System Continues to Expand in the Europe..., Inc., the leader in the development of devices f...unced today that the first series of patients have...ystem at the Cardiocentro Ticino in Lugano, Switze... device commercially available in the European Uni...

Other Medicine Technology:First Swiss Patients Treated with the Percutaneous MitraClip(R) System 2 First Swiss Patients Treated with the Percutaneous MitraClip(R) System 3

BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference First Swiss Patients Treated with the Percutaneous MitraClip(R) System

Shandon Histobath 2

Liquichek Blood Gas Plus CO-Oximeter Control (IL)

Liquichek CK/LD Isoenzyme Control

Lyphochek Diabetes Control

Medicine Products:

Shandon Histobath 2 Liquichek Blood Gas Plus CO-Oximeter Control (IL)Liquichek CK/LD Isoenzyme Control Lyphochek Diabetes Control

Warner Chilcott Reports Operating Results for the Quarter Ended Septembe...(33.1 19.7 97.3 37.7...),Health